Presentation is loading. Please wait.

Presentation is loading. Please wait.

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient 

Similar presentations


Presentation on theme: "Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient "— Presentation transcript:

1 Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient  Jeff T Edwards, BS, CCP, James K Hamby, BS, CCP, Neil K Worrall, MD  The Annals of Thoracic Surgery  Volume 75, Issue 5, Pages (May 2003) DOI: /S (02) Copyright © 2003 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Timeline for Argatroban administration and resultant dose-response in the ACT and HiTT. Open bars = ACT; filled bars = HiTT. (ACT = activated clotting time; CPB = cardiopulmonary bypass; HiTT = high-dose thrombin time.) The Annals of Thoracic Surgery  , DOI: ( /S (02) ) Copyright © 2003 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient "

Similar presentations


Ads by Google